346 related articles for article (PubMed ID: 31405197)
41. Evidence of dual sites of action of dendrimers: SPL-2999 inhibits both virus entry and late stages of herpes simplex virus replication.
Gong Y; Matthews B; Cheung D; Tam T; Gadawski I; Leung D; Holan G; Raff J; Sacks S
Antiviral Res; 2002 Aug; 55(2):319-29. PubMed ID: 12103432
[TBL] [Abstract][Full Text] [Related]
42. Resveratrol suppresses nuclear factor-kappaB in herpes simplex virus infected cells.
Faith SA; Sweet TJ; Bailey E; Booth T; Docherty JJ
Antiviral Res; 2006 Dec; 72(3):242-51. PubMed ID: 16876885
[TBL] [Abstract][Full Text] [Related]
43. The immunosuppressive agent mycophenolate mofetil markedly potentiates the activity of lobucavir [1R(1alpha,2beta,3alpha)]-9-[2,3-bis(hydroxymethyl)cyclobutyl]guanine against different herpes viruses.
Neyts J; De Clercq E
Transplantation; 1999 Mar; 67(5):760-4. PubMed ID: 10096537
[TBL] [Abstract][Full Text] [Related]
44. Mode of action of (R)-9-[4-hydroxy-2-(hydroxymethyl)butyl]guanine against herpesviruses.
Lowe DM; Alderton WK; Ellis MR; Parmar V; Miller WH; Roberts GB; Fyfe JA; Gaillard R; Ertl P; Snowden W
Antimicrob Agents Chemother; 1995 Aug; 39(8):1802-8. PubMed ID: 7486922
[TBL] [Abstract][Full Text] [Related]
45. The Peptide A-3302-B Isolated from a Marine Bacterium
Sureram S; Arduino I; Ueoka R; Rittà M; Francese R; Srivibool R; Darshana D; Piel J; Ruchirawat S; Muratori L; Lembo D; Kittakoop P; Donalisio M
Int J Mol Sci; 2022 Jan; 23(2):. PubMed ID: 35055133
[TBL] [Abstract][Full Text] [Related]
46. [Anti-herpes simplex virus type Ⅰ of tectorigenin derivative and effect on Toll-like receptors in vitro].
Wang Y; Yuan MM; Zhou J; Zheng XH; Yuan CJ; Chen S; Luo S; Zhang L
Zhongguo Zhong Yao Za Zhi; 2022 Aug; 47(16):4428-4435. PubMed ID: 36046872
[TBL] [Abstract][Full Text] [Related]
47. Anti-HSV-1 activity of Aspergillipeptide D, a cyclic pentapepetide isolated from fungus Aspergillus sp. SCSIO 41501.
Wang Z; Jia J; Wang L; Li F; Wang Y; Jiang Y; Song X; Qin S; Zheng K; Ye J; Ren Z; Wang Y; Qi S
Virol J; 2020 Mar; 17(1):41. PubMed ID: 32192525
[TBL] [Abstract][Full Text] [Related]
48. Anti-HSV-2 activity of Terminalia chebula Retz extract and its constituents, chebulagic and chebulinic acids.
Kesharwani A; Polachira SK; Nair R; Agarwal A; Mishra NN; Gupta SK
BMC Complement Altern Med; 2017 Feb; 17(1):110. PubMed ID: 28196487
[TBL] [Abstract][Full Text] [Related]
49. Docking and antiherpetic activity of 2-aminobenzo[de]-isoquinoline-1,3-diones.
Al-Salahi R; Alswaidan I; Ghabbour HA; Ezzeldin E; Elaasser M; Marzouk M
Molecules; 2015 Mar; 20(3):5099-111. PubMed ID: 25808153
[TBL] [Abstract][Full Text] [Related]
50. Inhibition of herpes simplex virus type 1 and type 2 infections by peptide-derivatized dendrimers.
Luganini A; Nicoletto SF; Pizzuto L; Pirri G; Giuliani A; Landolfo S; Gribaudo G
Antimicrob Agents Chemother; 2011 Jul; 55(7):3231-9. PubMed ID: 21576438
[TBL] [Abstract][Full Text] [Related]
51. In vitro inhibition of herpes simplex virus type 1 replication by Mentha suaveolens essential oil and its main component piperitenone oxide.
Civitelli L; Panella S; Marcocci ME; De Petris A; Garzoli S; Pepi F; Vavala E; Ragno R; Nencioni L; Palamara AT; Angiolella L
Phytomedicine; 2014 May; 21(6):857-65. PubMed ID: 24629600
[TBL] [Abstract][Full Text] [Related]
52. Hypericin blocks the function of HSV-1 alkaline nuclease and suppresses viral replication.
Cao K; Zhang Y; Yao Q; Peng Y; Pan Q; Jiao Q; Ren K; Sun F; Zhang Q; Guo R; Zhang J; Chen T
J Ethnopharmacol; 2022 Oct; 296():115524. PubMed ID: 35811028
[TBL] [Abstract][Full Text] [Related]
53. Anti HSV-2 activity of Peganum harmala (L.) and isolation of the active compound.
Benzekri R; Bouslama L; Papetti A; Hammami M; Smaoui A; Limam F
Microb Pathog; 2018 Jan; 114():291-298. PubMed ID: 29223449
[TBL] [Abstract][Full Text] [Related]
54. Antiviral Properties of the LSD1 Inhibitor SP-2509.
Harancher MR; Packard JE; Cowan SP; DeLuca NA; Dembowski JA
J Virol; 2020 Sep; 94(19):. PubMed ID: 32699090
[TBL] [Abstract][Full Text] [Related]
55. Effects of non toxic doses of acyclovir on nitric oxide and cellular death responses in herpesvirus types 1 and 2 infected hep-2 cells.
Baskin H; Yazici Z; Baskin Y; Olgun N; Ozkul A; Bahar IH
New Microbiol; 2005 Jul; 28(3):205-13. PubMed ID: 16240692
[TBL] [Abstract][Full Text] [Related]
56. Antiviral activity of PHA767491 against human herpes simplex virus in vitro and in vivo.
Hou J; Zhang Z; Huang Q; Yan J; Zhang X; Yu X; Tan G; Zheng C; Xu F; He S
BMC Infect Dis; 2017 Mar; 17(1):217. PubMed ID: 28320320
[TBL] [Abstract][Full Text] [Related]
57. Antiviral activity of esterified alpha-lactalbumin and beta-lactoglobulin against herpes simplex virus type 1. Comparison with the effect of acyclovir and L-polylysines.
Sitohy M; Billaudel S; Haertlé T; Chobert JM
J Agric Food Chem; 2007 Dec; 55(25):10214-20. PubMed ID: 17990848
[TBL] [Abstract][Full Text] [Related]
58. Biosynthesis and half-life of MBX-2168-triphosphate in herpes virus-infected cells.
Sauer HE; Nguyen ML; Williams JD; Bowlin TL; Gentry BG
Antiviral Res; 2020 Mar; 175():104713. PubMed ID: 31968222
[TBL] [Abstract][Full Text] [Related]
59. Samarangenin B from Limonium sinense suppresses herpes simplex virus type 1 replication in Vero cells by regulation of viral macromolecular synthesis.
Kuo YC; Lin LC; Tsai WJ; Chou CJ; Kung SH; Ho YH
Antimicrob Agents Chemother; 2002 Sep; 46(9):2854-64. PubMed ID: 12183238
[TBL] [Abstract][Full Text] [Related]
60. ASP2151, a novel helicase-primase inhibitor, possesses antiviral activity against varicella-zoster virus and herpes simplex virus types 1 and 2.
Chono K; Katsumata K; Kontani T; Kobayashi M; Sudo K; Yokota T; Konno K; Shimizu Y; Suzuki H
J Antimicrob Chemother; 2010 Aug; 65(8):1733-41. PubMed ID: 20534624
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]